Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Hypertension Awareness, Treatment, and Control in Chronic Kidney Disease Pantelis A. Sarafidis, MD, PhD, Suying Li, PhD, Shu-Cheng Chen, MS, Allan J.

Quiz Page April 2011 American Journal of Kidney Diseases

Uric Acid and Long-term Outcomes in CKD

KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD Mark J. Sarnak, MD, MS, Roy Bloom, MD, Paul Muntner, PhD,

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Prevalence of and Risk Factors.

Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A

Peter A. McCullough, MD, MPH, Timothy Larsen, DO, Jeremiah R

Peritoneal dialysis American Journal of Kidney Diseases

Quiz Page March 2008 American Journal of Kidney Diseases

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.

Edmund J. Bini, MD, MPH, Aditi Kinkhabwala, MD, David S. Goldfarb, MD

A Decade After the KDOQI CKD Guidelines

Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study Equations: Risk Factors for and Complications.

Sustainable Community-Based CKD Screening Methods Employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Peter A. McCullough,

Determinants of Plasma Adiponectin Levels in Nondiabetic Subjects With Moderate to Severe Chronic Kidney Disease Luis F. Ramos, MD, Ayumi Shintani, PhD,

Awareness and Knowledge of Clinical Practice Guidelines for CKD Among Internal Medicine Residents: A National Online Survey Varun Agrawal, MD, Amit K.

Risk Factors for ESRD in Individuals With Preserved Estimated GFR With and Without Albuminuria: Results From the Kidney Early Evaluation Program (KEEP)

Jayme E. Locke, MD, MPH American Journal of Kidney Diseases

Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.

Evaluation of the Potential Living Kidney Donor

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

National Kidney Foundation American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

Applying an Expanded Set of Cognitive Design Principles to Formatting the Kidney Early Evaluation Program (KEEP) Longitudinal Survey José Luis Calderón,

The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population Claudine T. Jurkovitz, MD, MPH, Yang Qiu,

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Navdeep Tangri, MD, FRCPC, Daniel E. Weiner, MD, MS

Usability Testing and Acceptance of an Electronic Medication Inquiry System for CKD Patients Clarissa J. Diamantidis, MD, MHS, Marni Zuckerman, MA, Wanda.

Sankar D. Navaneethan, MD, MPH, Suetonia C. Palmer, MBChB, Jonathan C

The Map Is Not the Territory—Mapping Out the Course and Cost of CKD

Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

CPR 1.2.: Evaluation of Anemia in CKD

Performance of GFR Estimating Equations Stratified by Measured or Estimated GFR: Implications for Interpretation Jonas Björk, PhD, Anders Grubb, MD,

Beef Tea, Vitality, Creatinine, and the Estimated GFR

A Timely Evaluation of the Psychometric Properties of the KDQOL-36

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Daniel T. Lackland, DrPH, David J.P. Barker, MD, PhD

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

George L. Bakris, MD, John M. Burkart, MD, Eric D

Racial Differences in Kidney Function Among Individuals With Obesity and Metabolic Syndrome: Results From the Kidney Early Evaluation Program (KEEP)

Risk for Incident Renal Dialysis in a Managed Care Population

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Trial Quality in Nephrology: How Are We Measuring Up?

Removal of Dabigatran by Hemodialysis

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2011: Executive Summary Adam T. Whaley-Connell, DO, MSPH, Joseph.

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), Madhav V. Rao,

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Applying an Expanded Set of Cognitive Design Principles to Formatting the Kidney Early Evaluation Program (KEEP) Longitudinal Survey José Luis Calderón,

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Dialysis Research and N-of-1 Trials: Made for Each Other?

Quiz Page January 2010 American Journal of Kidney Diseases

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

Racial and Ethnic Differences in Albuminuria in Individuals With Estimated GFR Greater Than 60 mL/min/1.73 m2: Results From the Kidney Early Evaluation.

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Adam Whaley-Connell, DO, MSPH

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

James A. Sloand, MD, Mark A. Shelly, MD

What Should a Guideline Panel Do When Evidence Is Inconclusive

Medication Adherence Behavior and Priorities Among Older Adults With CKD: A Semistructured Interview Study Dena E. Rifkin, MD, MS, M. Barton Laws, PhD,

Presentation transcript:

Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP) Rohit Bhuriya, MD, Suying Li, PhD, Shu-Cheng Chen, MS, Peter A. McCullough, MD, MPH, George L. Bakris, MD American Journal of Kidney Diseases Volume 53, Issue 4, Pages S3-S10 (April 2009) DOI: 10.1053/j.ajkd.2008.11.029 Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Cardiovascular disease prevalence stratified by parathyroid hormone (PTH) level. P < 0.001 for Cochran-Armitage trend test. PTH levels expressed in pg/mL and ng/L are equivalent. American Journal of Kidney Diseases 2009 53, S3-S10DOI: (10.1053/j.ajkd.2008.11.029) Copyright © 2009 National Kidney Foundation, Inc. Terms and Conditions